Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Enlivex Therapeutics Ltd. (1BT.F)

0.7950
+0.0150
+(1.92%)
As of 8:02:51 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
16,146
25,151
25,797
19,288
9,785
Operating Income
-16,146
-25,151
-25,797
-19,288
-9,785
Net Non Operating Interest Income Expense
2,882
1,551
821
-208
219
Other Income Expense
-2,633
-5,468
-6,084
5,028
-2,258
Pretax Income
-18,933
-29,068
-31,060
-14,468
-11,824
Net Income Common Stockholders
-18,933
-29,068
-31,060
-14,468
-11,824
Diluted NI Available to Com Stockholders
-18,933
-29,068
-31,060
-14,468
-11,824
Basic EPS
-1.18
-1.56
-1.69
-0.81
-0.90
Diluted EPS
-1.18
-1.56
-1.69
-0.81
-0.90
Basic Average Shares
18,868.1660
18,574.4840
18,394.8860
17,859.7130
13,169.2080
Diluted Average Shares
18,868.1660
18,574.4840
18,394.8860
17,859.7130
13,169.2080
Total Operating Income as Reported
-20,591
-29,395
-25,797
-19,288
-9,785
Total Expenses
16,146
25,151
25,797
19,288
9,785
Net Income from Continuing & Discontinued Operation
-18,933
-29,068
-31,060
-14,468
-11,824
Normalized Income
-13,264
-23,600
-24,976
-19,496
-9,566
Interest Income
--
1,565
835
120
225
Net Interest Income
2,882
1,551
821
-208
219
EBIT
-16,146
-25,151
-25,797
-19,288
-9,785
EBITDA
-15,437
-24,316
-25,020
-18,742
-9,499
Reconciled Depreciation
709
835
777
546
286
Net Income from Continuing Operation Net Minority Interest
-18,933
-29,068
-31,060
-14,468
-11,824
Total Unusual Items Excluding Goodwill
-5,669
-5,468
-6,084
5,028
-2,258
Total Unusual Items
-5,669
-5,468
-6,084
5,028
-2,258
Normalized EBITDA
-9,768
-18,848
-18,936
-23,770
-7,241
12/31/2020 - 7/23/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PYPD PolyPid Ltd.
2.6700
-2.91%
 
BCDA BioCardia, Inc.
1.8292
-1.66%
 
CELU Celularity Inc.
1.6850
+4.66%
 
ALZN Alzamend Neuro, Inc.
0.6609
-3.53%
 
CVKD Cadrenal Therapeutics, Inc.
16.91
+0.18%
 
BCLI Brainstorm Cell Therapeutics Inc.
0.8800
+1.25%
 
LGVN Longeveron Inc.
1.6430
+2.04%
 
BSEM BioStem Technologies, Inc.
13.99
+19.57%
 
LXEO Lexeo Therapeutics, Inc.
3.4600
+2.68%
 
VIR Vir Biotechnology, Inc.
6.12
+2.51%